Your browser doesn't support javascript.
loading
miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.
Muys, Bruna Rodrigues; Sousa, Josane F; Plaça, Jessica Rodrigues; de Araújo, Luíza Ferreira; Sarshad, Aishe A; Anastasakis, Dimitrios G; Wang, Xiantao; Li, Xiao Ling; de Molfetta, Greice Andreotti; Ramão, Anelisa; Lal, Ashish; Vidal, Daniel Onofre; Hafner, Markus; Silva, Wilson A.
Afiliación
  • Muys BR; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Sousa JF; Center for Cell-Based Therapy (CEPID/FAPESP), National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Ribeirão Preto, Brazil.
  • Plaça JR; Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi-NAP/USP), Ribeirão Preto, Brazil.
  • de Araújo LF; Laboratory of Muscle Stem Cells and Gene Regulation, National Institute for Arthritis and Musculoskeletal and Skin Disease, Bethesda, Maryland.
  • Sarshad AA; Regulatory RNAs and Cancer Section, Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Anastasakis DG; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Wang X; Center for Cell-Based Therapy (CEPID/FAPESP), National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Ribeirão Preto, Brazil.
  • Li XL; Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi-NAP/USP), Ribeirão Preto, Brazil.
  • de Molfetta GA; Genetics and Molecular Biology Program, Institute of Biological Sciences, Federal University of Para-UFPA, Belem, Brazil.
  • Ramão A; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Lal A; Center for Cell-Based Therapy (CEPID/FAPESP), National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Ribeirão Preto, Brazil.
  • Vidal DO; Center for Medical Genomics (HCFMRP/USP), Center for Integrative Systems Biology (CISBi-NAP/USP), Ribeirão Preto, Brazil.
  • Hafner M; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Silva WA; Center for Cell-Based Therapy (CEPID/FAPESP), National Institute of Science and Technology in Stem Cell and Cell Therapy (INCTC/CNPq), Regional Blood Center of Ribeirão Preto, Ribeirão Preto, Brazil.
Cancer Res ; 79(13): 3294-3305, 2019 07 01.
Article en En | MEDLINE | ID: mdl-31101765
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / MicroARNs / Metabolismo Energético / Transición Epitelial-Mesenquimal Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Brasil
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / MicroARNs / Metabolismo Energético / Transición Epitelial-Mesenquimal Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Brasil